Publisher Correction: The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group.

Journal

Nature reviews. Nephrology
ISSN: 1759-507X
Titre abrégé: Nat Rev Nephrol
Pays: England
ID NLM: 101500081

Informations de publication

Date de publication:
Feb 2019
Historique:
pubmed: 21 12 2018
medline: 21 12 2018
entrez: 21 12 2018
Statut: ppublish

Résumé

In the key to Figure 1 of this article, 'Amyloid microtubules' has been corrected to 'Microtubules'.

Identifiants

DOI: 10.1038/s41581-018-0102-7 PMID: 30568288 PMC: PMC7608309
pubmed: 30568288
doi: 10.1038/s41581-018-0102-7
pii: 10.1038/s41581-018-0102-7
pmc: PMC7608309
doi:

Types de publication

Published Erratum

Langues

eng

Pagination

121

Subventions

Organisme : BLRD VA
ID : I01 BX001192
Pays : United States
Organisme : CSRD VA
ID : I01 CX001326
Pays : United States

Commentaires et corrections

Type : ErratumFor

Auteurs

Nelson Leung (N)

Division of Nephrology, Hematology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA. leung.nelson@mayo.edu.

Frank Bridoux (F)

Department of Nephrology, Centre Hospitalier Universitaire et Université de Poitiers, Poitiers, France; CNRS UMR7276, Limoges, France; and Centre de Référence Amylose AL et Autres Maladies par Dépôt d'Immunoglobulines Monoclonales, Poitiers, France.

Vecihi Batuman (V)

Veterans Administration Medical Center, New Orleans, LA, USA and Tulane University Medical School, Tulane, LA, USA.

Aristeidis Chaidos (A)

Centre for Haematology, Department of Medicine, Imperial College London and Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, UK.

Paul Cockwell (P)

Department of Nephrology, Renal Medicine - University Hospitals Birmingham NHS Foundation Trust, Queen Elizabeth Hospital, Birmingham, UK.

Vivette D D'Agati (VD)

Department of Pathology, Renal Pathology Laboratory, Columbia University, College of Physicians and Surgeons, New York, NY, USA.

Angela Dispenzieri (A)

Division of Nephrology, Hematology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.

Fernando C Fervenza (FC)

Division of Nephrology, Hematology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.

Jean- Paul Fermand (JP)

Department of Haematology and Immunology, University Hospital St Louis, Paris, France.

Simon Gibbs (S)

The Victorian and Tasmanian Amyloidosis Service, Department of Haematology, Monash Univerity Easter Health Clinical School, Melbourne, Victoria, Australia.

Julian D Gillmore (JD)

National Amyloidosis Centre, Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, Royal Free Campus, University College London, London, UK.

Guillermo A Herrera (GA)

Department of Pathology and Translational Pathobiology, Louisiana State University Health Sciences Center, Shreveport, LA, USA.

Arnaud Jaccard (A)

Service d'Hématologie et de Thérapie Cellulaire, Centre de Référence des Amyloses Primitives et des Autres Maladies par Dépôts d'Immunoglobuline, CHU Limoges, Limoges, France.

Dragan Jevremovic (D)

Division of Nephrology, Hematology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.

Efstathios Kastritis (E)

Department of Clinical Therapeutics, School of Medicine National and Kapodistrian University of Athens Alexandra Hospital, Athens, Greece.

Vishal Kukreti (V)

University Health Network, Princess Margaret Cancer Centre, Toronto, Canada.

Robert A Kyle (RA)

Division of Nephrology, Hematology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.

Helen J Lachmann (HJ)

National Amyloidosis Centre, Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, Royal Free Campus, University College London, London, UK.

Christopher P Larsen (CP)

Arkana Laboratories, Little Rock, AR, USA.

Heinz Ludwig (H)

Wilhelminen Cancer Research Institute, Wilhelminenspital, Vienna, Austria.

Glen S Markowitz (GS)

Department of Pathology, Renal Pathology Laboratory, Columbia University, College of Physicians and Surgeons, New York, NY, USA.

Giampaolo Merlini (G)

Amyloidosis Research and Treatment Center, IRCCS Policlinico San Matteo, University of Pavia, Pavia, Italy.

Peter Mollee (P)

Haematology Department, Princess Alexandra Hospital and School of Medicine, University of Queensland, Brisbane, Australia.

Maria M Picken (MM)

Department of Pathology, Loyola University Medical Center, Maywood, IL, USA.

Vincent S Rajkumar (VS)

Division of Nephrology, Hematology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.

Virginie Royal (V)

Department of Pathology, Hôpital Maisonneuve- Rosemont, Université de Montreal, Montreal, Quebec, Canada.

Paul W Sanders (PW)

Department of Medicine, University of Alabama at Birmingham and Department of Veterans Affairs Medical Center, Birmingham, AL, USA.

Sanjeev Sethi (S)

Division of Nephrology, Hematology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.

Christopher P Venner (CP)

Cross Cancer Institute, University of Alberta, Edmonton, Alberta, Canada.

Peter M Voorhees (PM)

Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium System, Charlotte, NC, USA.

Ashutosh D Wechalekar (AD)

National Amyloidosis Centre, Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, Royal Free Campus, University College London, London, UK.

Brendan M Weiss (BM)

Abramson Cancer Center, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA.

Samih H Nasr (SH)

Division of Nephrology, Hematology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.

Classifications MeSH